MartÃn, E.; López-Aguilera, J.; González-Manzanares, R.; Anguita, M.; Gutiérrez, G.; Luque, A.; Paredes, N.; Oneto, J.; Perea, J.; Castillo, J.C.
Impact of Canagliflozin in Patients with Type 2 Diabetes after Hospitalization for Acute Heart Failure: A Cohort Study. J. Clin. Med. 2021, 10, 505.
https://doi.org/10.3390/jcm10030505
AMA Style
MartÃn E, López-Aguilera J, González-Manzanares R, Anguita M, Gutiérrez G, Luque A, Paredes N, Oneto J, Perea J, Castillo JC.
Impact of Canagliflozin in Patients with Type 2 Diabetes after Hospitalization for Acute Heart Failure: A Cohort Study. Journal of Clinical Medicine. 2021; 10(3):505.
https://doi.org/10.3390/jcm10030505
Chicago/Turabian Style
MartÃn, Ernesto, José López-Aguilera, Rafael González-Manzanares, Manuel Anguita, Guillermo Gutiérrez, Aurora Luque, Nick Paredes, Jesús Oneto, Jorge Perea, and Juan Carlos Castillo.
2021. "Impact of Canagliflozin in Patients with Type 2 Diabetes after Hospitalization for Acute Heart Failure: A Cohort Study" Journal of Clinical Medicine 10, no. 3: 505.
https://doi.org/10.3390/jcm10030505
APA Style
MartÃn, E., López-Aguilera, J., González-Manzanares, R., Anguita, M., Gutiérrez, G., Luque, A., Paredes, N., Oneto, J., Perea, J., & Castillo, J. C.
(2021). Impact of Canagliflozin in Patients with Type 2 Diabetes after Hospitalization for Acute Heart Failure: A Cohort Study. Journal of Clinical Medicine, 10(3), 505.
https://doi.org/10.3390/jcm10030505
